Global single photon emission computed tomography market is estimated to be valued at USD 3.13 Bn in 2024 and is expected to reach USD 4.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
Single photon emission computed tomography (SPECT) is a nuclear medicine tomographic imaging technique that uses gamma rays. SPECT imaging provides 3D information by measuring gamma radiation from multiple angles around the patient. Radiotracer, labeled with gamma-emitting radionuclides, is injected into the body and concentrated in specific organs, bones or tissues. The data collected from multiple detectors is reconstructed by computer into 3D images showing the distribution of the radiotracer in different organs. Areas where the radiotracer accumulates can indicate abnormal tissue function. SPECT imaging helps physicians diagnose and evaluate various medical conditions like cancer, heart disease, neurological disorders, and others. Technological advancements in detector materials and imaging algorithms are improving image quality and diagnostic value of SPECT scans. Growing applications across multiple therapeutic areas is expected to drive the global single photon emission computed tomography market.
Market Dynamics:
Global single photon emission computed tomography market growth is primarily driven by rising geriatric population and prevalence of chronic diseases like cancer and cardiovascular disorders. SPECT scans are widely used for cancer staging, detecting recurrence and evaluating treatment response. According to data from WHO, cancer burden is projected to grow globally with over 27 million new cancer cases estimated in 2040. Heart diseases also pose a major healthcare challenge. Growing applications of SPECT imaging in neurology, infection imaging and other therapeutic areas are expected to offer new opportunities. However, high installation and maintenance costs of SPECT systems limit widespread adoption especially in price-sensitive developing countries. New product launches with advanced hardware and software are addressing these concerns. Ongoing research on novel radiotracers and targeted radiopharmaceuticals could enhance diagnostic specificity of SPECT scans.
Key Features of the Study:
Detailed Segmentation:
Detailed Segmentation:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients